Medical device company, INVO Bioscience sought FDA clearance for Intravaginal Culture System, INVOcell asserted that Alabama Fertility has augmented its scope of reproductive treatments with the addition of INVOcell.
INVOcell has the ability to remarkably transform the way in which doctors assist infertility patients to become pregnant in a simpler, more natural and cost-effective manner. INVOcell is a patented medical device utilized in thee treatment of infertility enabling egg fertilization and early embryo development to take place in the woman’s body , in vivo.
Beth A. Malizia, MD, a specialist in infertility and reproductive surgery at Alabama Fertility, said, “We are pleased to add INVOcell to our list of advanced fertility services. Infertility is a highly frustrating condition that afflicts many couples and individuals in Alabama and the greater southeastern U.S. We are dedicated to providing a broad scope of diagnosis and treatment options. INVOcell is a unique, cost effective, alternative that may result in pregnancy when other treatment options have failed. We believe that INVOcell is a fantastic addition to our scope of services.”